A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): a feasibility trial

A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): a feasibility trial

<br><strong>Background: </strong>Trials of lowering blood pressure in patients with acute ischaemic stroke not undergoing thrombolysis have not demonstrated improved outcomes with intervention. Rather than absolute levels, it may be that blood pressure variability is important. How...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Davison, WJ, Appiah, K, Robinson, TG, McGurgan, IJ, Rothwell, PM, Potter, JF
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2020

Míreanna comhchosúla

Randomised controlled trial of a calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduce blood pressure variability following ischaemic stroke (CAARBS): a protocol for a feasibility study
de réir: Robinson, T, et al.
Foilsithe / Cruthaithe: (2019)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
de réir: Myla E. Moretti, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy
de réir: Letian Zhou, et al.
Foilsithe / Cruthaithe: (2014-03-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
de réir: Hyun Woo Lee, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Monitoring and controlling blood pressure after stroke and transient ischaemic attack
de réir: McGurgan, I
Foilsithe / Cruthaithe: (2021)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
de réir: Hye-Ran Jun, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
de réir: Jin Sun Choi, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
de réir: S Bhuvaneshwari, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
de réir: Yudi Her Oktaviono, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
de réir: Ha Yeon Kim, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
de réir: Zhang C, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Is there any difference between angiotensin converting enzyme inhibitors and angiotensin receptor blockers for heart failure?
de réir: Carmen Rain, et al.
Foilsithe / Cruthaithe: (2015-07-01)

Safety and efficacy of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic allograft injury
de réir: P R Shah, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
de réir: Martin C.S. Wong, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
de réir: Éva Larouche‐Lebel, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
de réir: Terry Huh, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
de réir: Marco Rossato, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
de réir: Wissam Mekary, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19
de réir: Michael Pan, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
de réir: James A. Ker
Foilsithe / Cruthaithe: (2015-05-01)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality of Coronary Artery Bypass Grafting
de réir: Ahmad Sharafi, et al.
Foilsithe / Cruthaithe: (2015-10-01)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
de réir: Nitesh Gupta, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria
de réir: Feng-Yi Hsu, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
de réir: Semaan G. Kosseifi, et al.
Foilsithe / Cruthaithe: (2009-12-01)

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
de réir: Azadeh Khalili, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
de réir: Valentina Carubelli, et al.
Foilsithe / Cruthaithe: (2021-06-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
de réir: Tao Liu, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on the In-Hospital Mortality of COVID-19 Patients
de réir: Mohsen Gholinataj Jelodar, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy
de réir: Shiori Iwane, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Perioperative management of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of perioperative medicine practitioners
de réir: Sophie L.M. Walker, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction.
de réir: Chih-Wei Chen, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
de réir: Chih-Wei Chen, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
de réir: Marie Douillard, MD, et al.
Foilsithe / Cruthaithe: (2023-08-01)

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
de réir: Seyed Ali Sadjadi, et al.
Foilsithe / Cruthaithe: (2009-07-01)

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies
de réir: Kayeong Shin, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
de réir: Huang Shiou-Huei, et al.
Foilsithe / Cruthaithe: (2012-05-01)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
de réir: Bin Tu, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
de réir: Maki Komiyama, et al.
Foilsithe / Cruthaithe: (2020-07-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
de réir: G. Savarese, et al.
Foilsithe / Cruthaithe: (2015-09-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
de réir: E. V. Rebrova, et al.
Foilsithe / Cruthaithe: (2024-01-01)